COVID-19 candidate vaccines
On 31 December 2019, WHO was informed of a cluster of cases of pneumonia of unknown cause detected in Wuhan City, Hubei Province of China. The coronavirus disease (COVID-2019) was identified as the causative virus by Chinese authorities on 7 January. As part of WHO’s response to the outbreak, the R&D Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus.
On 30 January 2020, following the recommendations of the Emergency Committee, the WHO Director-General declared that the outbreak constitutes a Public Health Emergency of International Concern (PHEIC).
World scientists on COVID-19 met at the World Health Organization’s Geneva headquarters from 11 to 12 February 2020 to assess the current level of knowledge about the new virus, agree on critical research questions that need to be answered urgently, and ways to work together to accelerate and fund priority research that can contribute to curtail this outbreak and prepare for future outbreaks.
2019 Novel Coronavirus: Global Research and Innovation Forum: Towards a Research Roadmap/report
2019 Novel Coronavirus: Overview of the state of the art and outline of key knowledge gaps/slides
A coordinated Global Research Roadmap
This document presents a Global Research Roadmap with immediate, mid-term and longer-term priorities to build a robust global research response on the basis of the deliberations during the Global Research Forum. Please send comments or suggestions to email@example.com.